尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Moses Jennifer K.. Director active across 1 company, notably G1 Therapeutics, Inc.. In total, 3 filings have been logged. Activity tracked since 3 January 2022. The latest transaction was disclosed on 3 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Moses Jennifer K. has filed 5 reports in total. In the 5 recent reports available, the transactions run from 2022-01-05 to 2023-01-05, with the modal transaction nature listed as Attribution and total buy and sell amounts of EUR 0; the reports concern G1 Therapeutics, Inc., where she is CFO, and the largest displayed filings are EUR 1103.115785917574 on 2022-02-02.